Vickie Reed
Directeur/Membre du Conseil chez EVOKE PHARMA, INC.
Fortune : - $ au 30/06/2024
Profil
Actuellement, Vickie S. Reed occupe le poste de directrice financière et comptable chez Mirati Therapeutics, Inc. Elle est également membre du conseil d'administration d'Evoke Pharma, Inc. Mme Reed a obtenu un diplôme de premier cycle à l'université du Colorado.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOKE PHARMA, INC.
-.--% | 22/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Vickie Reed
| Sociétés | Poste | Début |
|---|---|---|
| EVOKE PHARMA, INC. | Directeur/Membre du Conseil | 13/05/2021 |
Anciens postes connus de Vickie Reed
| Sociétés | Poste | Fin |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 27/06/2024 |
| MIRATI THERAPEUTICS | Directeur Financier/CFO | 16/05/2022 |
| ZOGENIX, INC. | Directeur Financier/CFO | 01/01/2022 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Vickie Reed
| The University of Colorado | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EVOKE PHARMA, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
